1. Introduction {#s0005}
===============

Major depressive disorder (MDD) is a common disorder that affects a large proportion of the population by significantly impairing their occupational, social, and academic functioning ([@bb8015], [@bb8020]). Current treatments of antidepressant medications may be provided as an initial primary treatment for MDD, but they are far from satisfactory ([@bb0385], [@bb0390]) due to undesirable side effects and a delay in the onset of therapeutic action ([@bb0030], [@bb0525]).

In recent years, acupuncture has become a promising and effective alternative treatment for depression ([@bb0190], [@bb0195]; Im. [@bb0350]; Im. [@bb0355]). Studies suggest that acupuncture may work by inducing the release of norepinephrine, serotonin, and dopamine in the central nervous system ([@bb8000], [@bb8005]), all of which play a role in the pathophysiology of MDD ([@bb8030]).

As a popular alternative and complementary modality, acupuncture is gaining popularity in Western society. One challenge that remains, however, is incorporating it into mainstream medicine. One solution is to combine acupuncture with other conventional, mainstream treatments. Using the treatment of depression as an example, accumulating evidence has indicated that acupuncture combined with antidepressant medications is more effective than antidepressants alone, safe, well-tolerated, and has an early onset of action ([@bb0500], [@bb0525]) However, the lack of understanding regarding the underlying mechanisms of the combinative treatment of acupuncture and antidepressant medications has significantly slowed the attempt to incorporate this treatment into mainstream medicine.

In recent years, brain imaging techniques have been applied to investigate the physiopathology of depression and revealed that MDD is associated with structural and functional abnormalities in brain circuits involved in emotional processing, self-representation, reward, and external stimulus (stress, distress) interactions ([@bb0090], [@bb0165];[@bb0185], [@bb0240], [@bb0280]; D. A. [@bb0340], [@bb0420]). Many brain regions including the amygdala, hippocampus, insula, ventral striatum, ventral anterior cingulate gyrus, and prefrontal cortex are involved in the neural pathology and development of MDD ([@bb0215], [@bb0310], [@bb0315], [@bb0320]) and subthreshold depression ([@bb0180]). Among these brain regions, one of the most well-studied regions is the amygdala.

As part of the limbic system, the amygdala plays a vital role in emotional processing, fear learning, and motivation behaviors ([@bb0005], [@bb0055], [@bb0275], [@bb0300], [@bb0305]). Studies showed that compared with healthy controls, MDD patients showed abnormal elevated activity in the amygdala when presented with negative stimuli ([@bb0310], [@bb0405], [@bb0410], [@bb0415]). In a more recent meta-analysis, Ma ([@bb8010]) found that antidepressant medication in patients with mood disorders affects the amygdala by decreasing its activity during negative emotions and increasing its activity during positive emotions.

Seed-based resting-state functional connectivity (rsFC) is a method of functional brain imaging that can assess the temporal dependency of brain regions (seeds) during rest ([@bb0050]). rsFC allows for the study of the function of one or several brain regions in relation to its functional network and how the network contributes to brain procedures ([@bb0175]; Jessica S. [@bb0185]). It has also widely been used to reveal the underlying mechanisms of different diseases ([@bb0430]; J. [@bb0450], [@bb0460], [@bb0445], [@bb0510]), including depression (L. [@bb0450], [@bb0460], [@bb0445]; L. [@bb0455]). Previous studies suggested that acupuncture can significantly modulate rsFC in healthy subjects ([@bb0035], [@bb0100], [@bb0170]; P. [@bb0230], [@bb0345], [@bb0520]) and patient populations, such as patients with knee osteoarthritis (X. [@bb0070], [@bb0115]), migraine ([@bb0220], [@bb0225], [@bb0220], [@bb0225], [@bb0505]) and Alzheimer\'s disease (Z. [@bb0475]). Few studies ([@bb0490]), however, have analyzed rsFC changes resulting from repeated acupuncture treatments for MDD.

In this study, we investigated rsFC changes in the left and right amygdala before and after verum acupuncture plus fluoxetine and sham acupuncture plus fluoxetine in patients with MDD. Considering that brain activity dysfunction may vary between male and female subjects ([@bb0015], [@bb0040]), we only recruited female patients to increase the homogeneity of this study. We hypothesized that in contrast to sham acupuncture treatment, verum acupuncture treatment can modulate amygdala-related rsFC. In addition, rsFC changes may be associated with changes in the depressive symptoms of patients.

2. Materials and methods {#s0010}
========================

2.1. Participants {#s0015}
-----------------

The study protocol was approved by the Institutional Review Board of the 2nd Affiliated Hospital of Guangzhou University of Chinese Medicine. The study was enrolled online on the Chinese Clinical Trial Registry (ChiCTR) ([www.chictr.org.cn](http://www.chictr.org.cn){#ir0005}, ChiCTR-TRC-14,005,228). All patients were provided written informed consent before participation in the study. Patients with MDD were recruited for this study through community postings, and all eligible participants were required to meet the specific inclusion/exclusion criteria.

### 2.1.1. Inclusion criteria {#s0020}

1\) Women who met the criteria of depression in ICD-10; 2) standard score of Self-Rating Depression Scale (SDS) ≥ 53 or total score of Montgomery-Asberg depression rating scale (MADRS) ≥ 14; 3) aged 30--60 years old and able to provide voluntary informed consent; 4) right-handed; 5) primary school education or higher; and 6) normal cognitive functioning, with no aphasia or intellectual disabilities.

### 2.1.2. Exclusion criteria {#s0025}

1\) Refused to sign informed content; 2) pregnant or lactating women; 3) women with metallic implants; 4) used antipsychotics or antidepressants within a month before the study; 5) consumption of alcohol or illicit substances; 6) patients with severe damage of liver or kidney function, or with neurological deficits, rheumatologic disorders, cardiac disease, diabetes, malignant tumors or any other significant systemic disorders that might affect the results; 7) presence of severe psychoses (schizophrenia, mania, paranoid psychosis or depression with suicidal intent) or dementia; 8) presence of any somatic diseases (such as cerebral infarction, cerebral hemorrhage, Parkinson\'s or cerebral tumor) or any other significant systemic disorders that might affect the results.

2.2. Intervention {#s0030}
-----------------

All participants received fluoxetine (20 mg po qd) once per day plus verum or sham acupuncture treatment based on randomization.

2.3. Verum and sham acupuncture administration {#s0035}
----------------------------------------------

In this study, we applied abdominal acupuncture, an acupuncture modality ([@bb0515]) that has been proven to be effective for depression ([@bb0080], [@bb0250]; X. Y. [@bb0465], [@bb0485]). The advantage of abdominal acupuncture is that it only produces mild sensations, possibly making it more acceptable to patients.

Abdominal acupuncture is based on the Chinese Traditional Medicine theory that CV 8 (umbilicus) plays a crucial role in propelling and regulating the flow of Qi ([@bb0515]). Abdominal acupuncture uses only acupoints in the abdomen because these acupoints are close to important meridians and can easily communicate with five zang and six fu organs through channels like Conceptional Vessel, Governor Vessel, Thoroughfare Meridian and Belt Meridian. Based on a previous study from our group (X. Y. [@bb0470]), the acupoints applied in this study were: Zhongwan (RN12), Xiawan (RN10), Qihai (RN6), Guanyuan (RN4), Shangqu (KL17), Huaroumen (ST24), and Qipang (extra-point) ([Fig. 1](#f0005){ref-type="fig"}). This prescription could harmonize zang-fu five viscera, tonify qi, and replenish blood to relieve depression. An acupuncturist with \> 3 years of experience performed all acupuncture treatments.

Before acupuncture administration, each participant was asked to lie in a supine position and to wear a mask over her eyes. Then, the participant\'s abdomen was exposed and the skin was disinfected at the acupuncture points. Afterwards, an acupuncture specialist inserted fine needles (0.22 mm × 40 mm) through short plastic tubes or sheaths. The needles were inserted intramuscularly to a depth of 15--20 mm and were left in situ for 20 min. The patient\'s abdomen was covered with a basket underneath a sheet during the treatment period. Patients received abdominal acupuncture once a day for the first three days and subsequently once every three days for the remainder of the 8-week trial. We chose this paradigm so that the effect of acupuncture could be accumulated quickly, enhancing the confidence and compliance of patients at the beginning of the study.

For sham acupuncture, the acupoints were the same as in the real acupuncture group. Before sham abdominal acupuncture administration, each patient was asked to lie in a supine position and put a mask over her eyes. Then, the subject\'s abdomen was exposed and the acupoint areas were disinfected. Later, short plastic needle sheaths not containing any needles were tapped against the skin of the patient's acupoints, but no needles were inserted into the skin through the sheaths. Then, as with the verum treatment, the patient's abdomen was covered with a basket underneath a sheet during the 'treatment' period. The time and frequency of the sham abdominal acupuncture treatments were exactly the same as in the verum acupuncture group.

2.4. Clinical outcomes {#s0040}
----------------------

MADRS and SDS were used to assess the clinical outcomes. Both were evaluated at time points before the first treatment and after the final treatment.

2.5. MRI data acquisition {#s0045}
-------------------------

The fMRI brain imaging acquisition was conducted on a 1.5 Tesla Siemens Avanto MR scanner. T2\*-weighted functional images encompassing the whole brain were acquired with the gradient-echo EPI sequence (echo time: 30 ms, repetition time: 2000 ms, data matrix: 64 × 64, field of view: 240 mm, flip angle: 90°, slice thickness: 4 mm, interslice gap: 0.88 mm, 31 slices paralleled to the AC-PC line, and 180 time points acquired in 6 min). Two 6-minute resting-state fMRI scans were applied while the subjects were required to keep their eyes closed to relax the mind but not to fall asleep and not to think of anything in particular. High-resolution brain structural images were also acquired with a T1-weighted three-dimensional multi-echo magnetization-prepared rapid gradient-echo (MP-RAGE) sequence (repetition time: 1900 ms, echo time: 2.3 ms, data matrix: 256 × 256, field of view: 256 mm × 256 mm, slice thickness 1 mm, flip angle: 15°, and 176 sagittal slices covering the whole brain).

2.6. Statistical analysis {#s0050}
-------------------------

### 2.6.1. Clinical data analysis {#s0055}

Statistical analysis was performed using SPSS 19.0 Software (SPSS Inc., Chicago, IL, USA). Two sample *t*-test was used to compare baseline measurements between groups, and analysis of covariance (ANCOVA) was applied to compare MADRS and SDS scores before and after treatments between groups. Age was included in the model to adjust for its effects.

### 2.6.2. Resting-state fMRI data analysis {#s0060}

Functional data were preprocessed using SPM8 (Statistical Parametric Mapping. Welcome Department of Cognitive Neurology, London, UK; implemented by MATLAB R2012b, Math Works, Inc., Natick, MA, USA). During the preprocessing, images were realigned, segmented, and co-registered to each subject\'s high-resolution T1 scan, which was used in normalizing to the standard Montreal Neurological Institute (MNI) template. Images were also smoothed using an 8 mm full-width at half-maximum (FWHM) Gaussian kernel, filtered with a frequency window of 0.008--0.09 Hz. Subsequently, we segmented the brain into gray matter, white matter, and cerebrospinal fluid (CSF) for the removal of temporal confounding factors (white matter and CSF) ([@bb0480]). Finally, data were then submitted to motion correction using the artifact detection toolbox (<http://www.nitrc.org/projects/artifact_detect/>). Time points in subjects\' images were marked as outliers if the global signal exceeded three standard deviations from the mean or if scan-to-scan motion exceeded 0.5 mm deviation ([@bb0365]).

Resting-state functional connectivity analysis was conducted using the CONN toolbox v15.g ([@bb0480]) (<http://www.nitrc.org/projects/conn>). Bilateral amygdala seeds were generated from the AAL, ([@bb0375]) using WFU-Pick Atlas software ([@bb0255]) ([Fig. 2](#f0010){ref-type="fig"}a). Functional connectivity measures were computed between a seed region of interest (ROI) and every other voxel in the brain. In the calculations, we first extracted the residual BOLD time course from a given seed and then estimated its first-level correlation maps by computing Pearson's correlation coefficients between that time course and the time courses of all other voxels in the brain. Correlation coefficients were transformed into Fisher's 'Z'-scores, which increases normality and allows for improved second-level General Linear Model analyses.

Amygdala seed-to-voxel functional connectivity was estimated for each subject. Between-group analyses were performed to compare the rsFC change (post-treatment minus pre-treatment) between the two groups. In the calculations, two sample *t*-tests were adopted and a threshold of a voxel-wise p \< 0.005 (uncorrected) and cluster-level p \< 0.05 family-wise error correction was applied.

3. Results {#s0065}
==========

Of all forty-six subjects (22 in the verum group, 24 in the sham group) who participated the study, 36 subjects (18 in the verum group, 18 in the sham group) were scanned at week 0 and week 8. Six subjects from the sham acupuncture group dropped out (2 due to discomfort from treatment (headache and diarrhea), 1 due to a scheduling conflict, and 3 due to having had only one scan), and four subjects from the verum acupuncture group dropped out (3 due to having had only one fMRI scan and 1 due to a scheduling conflict). Thus, all of the clinical and imaging analyses were based on these 36 subjects.

No significant differences were found between the two groups in age (t~(34)~ = 0.22, p = 0.83) and MADRS (*F*~(1,33)~ = 0.01, p = 0.97) and SDS (*F*~(1,33)~ = 0.01, p = 0.94) scores at baseline ([Table 1](#t0005){ref-type="table"}). ANCOVA analysis revealed significant differences in both MADRS and SDS scores between the verum acupuncture and sham acupuncture groups. The verum acupuncture group showed significantly greater clinical improvement (post minus pre-treatment, MADRS, *F*~(1,33)~ = 10.86, p \< 0.01; SDS, *F* ~(1,33)~ = 8.21, p \< 0.01) compared to sham acupuncture ([Table 1](#t0005){ref-type="table"}).

3.1. Resting state functional connectivity results {#s0070}
--------------------------------------------------

Baseline analysis showed that there was no significant rsFC difference between the two groups at baseline. After 8 weeks of treatment, participants in the verum acupuncture group showed increased rsFC at the left amygdala-subgenual anterior cingulate cortex (sgACC)/pregeunal antieror cingulated cortex (pgACC) and right amygdala-paraphippocampus (Para)/putman (Pu) compared to baseline ([Table 2](#t0010){ref-type="table"}). The sham acupuncture plus fluoxetine group showed decreased rsFC between the right amygdala-left Para/Pu after eight weeks of treatment ([Table 2](#t0010){ref-type="table"}).

We also compared the increased rsFC (post-treatment minus pre-treatment) between the two groups. The results showed that the verum group showed significantly increased rsFC between the left amygdala and left sgACC/pgACC ([Table 2](#t0010){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}b) compared to the sham acupuncture group. The right amygdala showed significantly increased rsFC with the left Para/Pu ([Table 2](#t0010){ref-type="table"}, [Fig. 2](#f0010){ref-type="fig"}c) in the verum acupuncture group compared to the sham acupuncture group.

To explore the association between rsFC and each of the corresponding clinical outcomes, we extracted the Fisher 'Z' value (a sphere of 3 mm radius around the peak voxel) of the left sgACC/pgACC and the Pu/Para, and then applied a multiple regression analysis controlling for the age effect across all participants. The results showed that the increase of rsFC between the left amygdala and sgACC/pgACC was significantly negatively associated with MADRS (p = 0.02, FDR corrected) and SDS (p = 0.01, FDR corrected) scores across all subjects.

4. Discussion {#s0075}
=============

In this study, we investigated amygdala-related rsFC changes before and after eight weeks of acupuncture plus fluoxetine treatment as compared with sham acupuncture plus fluoxetine in female depressive disorder patients. Our results revealed a significant remission of depressive symptoms in the verum acupuncture plus fluoxetine group compared with the control group. In addition, we also found that verum acupuncture plus fluoxetine treatment can significantly increase the rsFC of the amygdala with brain regions associated with emotion and affect modulation. The rsFC changes in the amygdala were also significantly associated with a reduction in symptom severity as indicated by MADRS and SDS scores, implying that acupuncture plus fluoxetine treatment may achieve treatment effects by modulating the rsFC of the amygdala.

Consistent with previous pilot studies ([@bb0260]; J. I. [@bb0360], [@bb0380]; W. D. [@bb0450], [@bb0460], [@bb0445]; X. Y. [@bb0470]), we observed that acupuncture stimulation plus fluoxetine could effectively reduce the symptoms of depression. Interestingly, a paired *t*-test comparing pre and post-treatment clinical outcomes also indicates that the symptoms in the sham acupuncture plus fluoxetine group significantly decreased after treatment (MADRS: p \< 0.001; SDS: p \< 0.001). We speculate that this may be attributed to the treatment effect of fluoxetine. The additional effect of verum acupuncture demonstrated that acupuncture can be combined with pharmacological treatment to achieve a greater therapeutic effect in MDD patients.

Antidepressants including fluoxetine have been widely used as a basic treatment for MDD ([@bb0145], [@bb0200]). However, antidepressant treatments may produce undesirable side effects and a delay in the onset of therapeutic action ([@bb0030], [@bb0525]). In this study, we found that combining acupuncture with fluoxetine can produce greater improvement in MDD patients, which is consistent with findings from previous studies investigating the combinative effects of acupuncture and other treatments ([@bb0110]; Y. [@bb0235], [@bb0380], [@bb0500], [@bb0525]).

We found that after 8 weeks of treatment, the verum acupuncture plus fluoxetine treatment induced increased rsFC between the left amygdala and sgACC/pgACC and between the right amygdala and left putamen/parahippocampus. The sham acupuncture plus fluoxetine treatment induced decreased rsFC between the right amygdala and left Pu/Para. A direct comparison between the two groups showed that verum acupuncture plus fluoxetine induced increased rsFC between the left amygdala and sgACC/pgACC and between the right amygdala and Pu/Para compared with the sham group.

The sgACC, located underneath the genu of the corpus callosum, and the pgACC, anterior to the genu of the corpus callosum, are both affective subdivisions of the anterior cingulate cortex ([@bb0135], [@bb0325]; D. A. [@bb0335]). Specifically, the sgACC is implicated in automatic behavioral control, and the pgACC is involved in automatic attentional control based in part on their functional interaction with limbic structures such as the amygdala ([@bb0095], [@bb0105], [@bb0125]; D. A. [@bb0335], [@bb0400]). Compared with healthy controls, MDD patients show elevated activity in the amygdala and ACC areas in response to negative stimuli ([@bb0135], [@bb0395]), and they also show abnormal reduced functional connectivity between the amygdala and ACC ([@bb0025], [@bb0135], [@bb0245], [@bb0265], [@bb0440]). In addition, the region also plays an important role in the self-regulation of pain such as placebo analgesia ([@bb0045], [@bb0120], [@bb0200], [@bb0205], [@bb0285]) and acupuncture treatment of chronic pain (X. [@bb0075]; X. [@bb0075], [@bb0115], [@bb0220], [@bb0225]).

Both the sgACC and pgACC are considered as biomarkers to antidepressant response ([@bb0135], [@bb0310]; D. [@bb0330]; D. A. [@bb0340]) or the target of deep brain stimulation treatments ([@bb0135], [@bb0155], [@bb0400]) in MDD. For instance, previous studies found that antidepressant treatments can increase the connectivity of the amygdala-sgACC during the perception of sad faces (C. H. [@bb0060]) and threatening stimuli ([@bb0290]), and the connectivity of the pgACC-amygdala can be used to predict antidepressant response to ketamine in a working memory task context ([@bb0400]).

We also found increased rsFC between the right amygdala and a cluster of brain regions including the left parahippocampus and putamen in the verum acupuncture group. The parahippocampus is associated with memory encoding and retrieval, and it is also linked to emotional processing ([@bb0140], [@bb0150], [@bb0425], [@bb0435]). The connectivity of the parahippocampus with the amygdala has been proposed to mediate contextual processing and emotion, thus facilitating emotion understanding and expectations of the environment ([@bb0020], [@bb0210]). The altered rsFC between the amygdala and parahippocampus is a powerful discrimination between MDD and healthy controls ([@bb0495]). Chen et al. (C. H. [@bb0060]) found that after eight weeks of antidepressant treatment with fluoxetine hydrochloride, the coupling of the amygdala with the parahippocampus was normalized to the levels of healthy controls.

The putamen is implicated in reward and motivation ([@bb0135], [@bb0140], [@bb0370]). Previous fMRI studies have found that individuals suffering from depression have lower activation in the putamen during the perception of happy faces ([@bb0085], [@bb0215], [@bb0295]). A similar study ([@bb0160]) in adults with MDD using the bilateral amygdala as seeds found that patients showed greater amygdala-putamen connectivity compared with healthy controls during successful encoding of negative emotional memories. With antidepressant treatment, Chen et al. (C. H. [@bb0060]) observed increased coupling of the amygdala and putamen in depressed subjects, which is consistent with our results.

We also found that that acupuncture treatment produces different effects on the left and right amygdala rsFC, and the changes of left amygdala rsFC showed a negative association with depression symptoms. A recent fMRI study (C. H. [@bb0060]) showed that antidepressant treatments enhanced the connection between the left amygdala and right lateral prefrontal cortex in response to unmasked negative faces in depressed patients. Mccabe et al. ([@bb0270]) found reduced rsFC between the right amygdala and frontal cortex in healthy subjects when they were administrated with the antidepressants citalopram and reboxetine for seven days. We did not find amygdala and prefrontal cortex connectivity changes in our study. We speculate this is mainly due to using a different treatment modality, method, and patient population.

There are several limitations in our study. First, we used the total anatomical structure of the amygdala as seeds, while amygdala subregional structures, including the centromedial (stress), superficial (socio-affective), and basolateral (learning and memory) amygdala are involved in different emotion processing functions ([@bb0010], [@bb0130]). Further focus on the rsFC of amygdala subregions is still needed. Second, we only recruited female depressed patients to increase the homogeneity of the study, and thus, our external validity may only be applied to interpret the effects of acupuncture on female patients. More study is needed to validate these findings in male patients. Finally, we only focus on the added effect of acupuncture treatment to fixed doses of fluoxetine in this study; there is no placebo fluoxetine, which prevents us from exploring the effect and mechanism of fluoxetine as well as the interaction between fluoxetine and acupuncture.

In conclusion, we found that acupuncture plus fluoxetine treatment significantly modulates the rsFC between the amygdala and sgACC/pgACC in patients with MDD compared to sham acupuncture plus fluoxetine. This rsFC change is associated with clinical improvement. We believe this modulation effect may at least partly represent the underlying mechanism of acupuncture treatment of MDD when it is combined with fluoxetine.
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###### 

Demographic and Clinical Characteristics of participants in this study. Abbreviations: MADRS, Montgomery-Asberg depression rating scale; SDS, Self-rating depression scale.

Table 1

  Characteristic                                Conditions       Acupuncture mean (SD)   Sham mean (SD)
  --------------------------------------------- ---------------- ----------------------- ----------------
  No. of participants who completed the study                    18                      18
  Age (years old)                                                44.5 (10.47)            43.78 (9.10)
  MADRS                                         Pre-treatment    22.94 (7.36)            22.83 (9.17)
                                                Post-treatment   5.44 (5.37)             14.06 (4.39)
  SDS                                           Pre-treatment    47.833 (6.46)           47.44 (9.23)
                                                Post-treatment   26.83 (6.46)            34.94 (5.40)

###### 

Regions showed significantly increased resting-state functional connectivity between the amygdala and other brain regions after acupuncture treatment and sham treatment, controlling for age as a covariate (voxel-wise, p \< 0.005, uncorrected; cluster --wise, p \< 0.05, FWE corrected). Abbreviations: AUC, acupuncture; sgACC, subgenual anterior cingulate cortex; pgACC, pregenual anterior cingulate cortex; Para, parahippocampus; Pu, putamen.

Table 2

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Group                                         Condition                         Seed             Brain region       Cluster size\   Peak coordinate (MNI space)   Peak Z-value          
                                                                                                                      mm^3^                                                               
  --------------------------------------------- --------------------------------- ---------------- ------------------ --------------- ----------------------------- -------------- ------ ------
  ACU plus fluoxetine                           Post-treatment \> pre-treatment   Left amygdala    Left sgACC/pgACC   278             − 4                           24             − 20   3.78

  Right amygdala                                Left Para/Pu                      325              − 28               − 2             − 12                          3.86                  

  Sham plus fluoxetine                          Post-treatment \< pre-treatment   Right amygdala   Left Para/Pu       359             − 28                          − 2            − 12   3.53

  ACU plus fluoxetine \> Sham plus fluoxetine   Post-treatment \> pre-treatment   Left amygdala    Left sgACC/pgACC   310             − 14                          28             − 22   3.64

  Right amygdala                                Left Para/Pu                      352              − 28               − 2             − 12                          3.74                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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